Insider · CIK 0001322481
Iwanicki David
Reports to the SEC for 1 company · FREMONT, CA
Transactions
41
Companies
1
Filings
4
CIK
0001322481
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2008-01-02 | PDL BIOPHARMA, INC.S Sale | −$870.5 |
| 2008-01-02 | PDL BIOPHARMA, INC.S Sale | −$1,450.185 |
| 2008-01-02 | PDL BIOPHARMA, INC.S Sale | −$462.267 |
| 2008-01-02 | PDL BIOPHARMA, INC.S Sale | −$342.82 |
| 2008-01-02 | PDL BIOPHARMA, INC.S Sale | −$1,633.145 |
| 2008-01-02 | PDL BIOPHARMA, INC.S Sale | −$1,035.66 |
| 2007-10-02 | PDL BIOPHARMA, INC.M Exercise/Conversion | +$11K |
| 2007-10-02 | PDL BIOPHARMA, INC.S Sale | −$14.6K |
| 2007-10-02 | PDL BIOPHARMA, INC.Employee Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2007-07-03 | PDL BIOPHARMA, INC.S Sale | −$93.84 |
| 2007-07-03 | PDL BIOPHARMA, INC.S Sale | −$609.7 |
| 2007-07-03 | PDL BIOPHARMA, INC.S Sale | −$1,413 |
| 2007-07-03 | PDL BIOPHARMA, INC.S Sale | −$3,502.5 |
| 2007-07-03 | PDL BIOPHARMA, INC.S Sale | −$1,452.04 |
| 2007-06-20 | PDL BIOPHARMA, INC.M Exercise/Conversion | +$11K |
| 2007-06-20 | PDL BIOPHARMA, INC.S Sale | −$1,461 |
| 2007-06-20 | PDL BIOPHARMA, INC.S Sale | −$1,579.5 |
| 2007-06-20 | PDL BIOPHARMA, INC.S Sale | −$1,580.8 |
| 2007-06-20 | PDL BIOPHARMA, INC.S Sale | −$1,581.45 |
| 2007-06-20 | PDL BIOPHARMA, INC.S Sale | −$1,583.4 |
| 2007-06-20 | PDL BIOPHARMA, INC.S Sale | −$1,587.95 |
| 2007-06-20 | PDL BIOPHARMA, INC.S Sale | −$1,591.2 |
| 2007-06-20 | PDL BIOPHARMA, INC.S Sale | −$1,592.5 |
| 2007-06-20 | PDL BIOPHARMA, INC.S Sale | −$1,594.45 |
| 2007-06-20 | PDL BIOPHARMA, INC.S Sale | −$1,595.75 |
| 2007-06-20 | PDL BIOPHARMA, INC.Employee Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2007-04-20 | PDL BIOPHARMA, INC.M Exercise/Conversion | +$11K |
| 2007-04-20 | PDL BIOPHARMA, INC.S Sale | −$1,527.68 |
| 2007-04-20 | PDL BIOPHARMA, INC.S Sale | −$1,528.32 |
| 2007-04-20 | PDL BIOPHARMA, INC.S Sale | −$3,189.34 |
| 2007-04-20 | PDL BIOPHARMA, INC.S Sale | −$1,520.64 |
| 2007-04-20 | PDL BIOPHARMA, INC.S Sale | −$1,524.48 |
| 2007-04-20 | PDL BIOPHARMA, INC.S Sale | −$1,527.68 |
| 2007-04-20 | PDL BIOPHARMA, INC.S Sale | −$1,532.16 |
| 2007-04-20 | PDL BIOPHARMA, INC.S Sale | −$1,532.8 |
| 2007-04-20 | PDL BIOPHARMA, INC.S Sale | −$1,546.24 |
| 2007-04-20 | PDL BIOPHARMA, INC.Employee Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2006-12-26 | PDL BIOPHARMA, INC.M Exercise/Conversion | +$34.4K |
| 2006-12-26 | PDL BIOPHARMA, INC.S Sale | −$44.2K |
| 2006-12-26 | PDL BIOPHARMA, INC.Employee Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2006-07-05 | PDL BIOPHARMA, INC.S Sale | −$5,846.999 |
Recent filings
- 4PDL BIOPHARMA, INC.0001140361-08-000243SEC(opens sec.gov)
- 4PDL BIOPHARMA, INC.0001140361-07-019181SEC(opens sec.gov)
- 4PDL BIOPHARMA, INC.0001140361-07-013639SEC(opens sec.gov)
- 4Iwanicki David0001140361-07-012727SEC(opens sec.gov)
Companies
Address
C/O PDL BIOPHARMA, INC. 34801 CAMPUS DRIVE
FREMONT, CA, 94555